Related Experiment Video
Updated: Jul 31, 2025
08:46
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
Published on: March 7, 2017
17.0K
Epigenetic and Metabolic Changes in Diffuse Intrinsic Pontine Glioma
Jiyoon Park1,2, Chan Chung1,3
1Department of New Biology, Daegu Gyeongbuk Institute of Science and Technology (DGIST), Daegu, Korea.
Brain Tumor Research and Treatment
|May 8, 2023
Summary
Diffuse midline glioma (DMG), also known as diffuse intrinsic pontine glioma (DIPG), is a pediatric brain cancer. H3K27M mutations disrupt epigenetic regulation and alter cell metabolism, driving tumor growth and progression.
Area of Science:
- Pediatric Oncology
- Epigenetics
- Cancer Metabolism
Background:
- Diffuse midline glioma (DMG), previously diffuse intrinsic pontine glioma (DIPG), is a rare, aggressive pediatric brain cancer.
- A significant proportion of DMG/DIPG tumors feature H3K27M mutations in histone H3.
- These mutations disrupt crucial epigenetic regulatory mechanisms.
Purpose of the Study:
- To investigate the role of epigenetic dysregulation and metabolic alterations in DMG/DIPG development.
- To understand how H3K27M mutations impact gene expression and cellular processes.
- To identify potential therapeutic targets for DMG/DIPG.
Main Methods:
- Analysis of histone modifications (H3K27me3, H3K27ac) in DMG/DIPG.
- Assessment of polycomb repressive complex 2 (PRC2) function.
- Investigation of metabolic pathway alterations, including methionine, TCA cycle, glucose, and glutamine metabolism.
Main Results:
- H3K27M mutations decrease H3K27me3 levels and impair PRC2 function, leading to aberrant gene expression.
- Increased H3K27ac levels correlate with active transcription in tumor cells.
- DMG/DIPG exhibits significant alterations in cellular metabolism, affecting key pathways.
Conclusions:
- Epigenetic dysregulation and metabolic reprogramming are critical drivers of DMG/DIPG.
- Understanding these molecular changes is essential for developing targeted therapies.
- Ongoing research aims to identify novel therapeutic strategies for this challenging pediatric cancer.
Keywords:
Diffuse intrinsic pontine gliomaDiffuse midline gliomaEpigenomicsHistone codeMetabolomicsTherapeutics
